NCT04709276 A Study of Chemoimmunotherapy for the Treatment of Men With Neuroendocrine or Aggressive Variant Metastatic Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04662580 ARX517/JNJ-95298177 as Monotherapy or Combination Therapy in Subjects With Metastatic Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04545697 mHealth ElectroNic COnsultation REcording (mENCORE) in Advanced Prostate Cancer Status COMPLETED Phase NA
NCT04533958 Evaluation of Hypnosis in Virtual Reality on the Anxiety of Patients With Metastatic Prostate Cancer Over Chemotherapy Status COMPLETED Phase NA
NCT04528199 [18F]FLOR (FC303) PET/CT Imaging in Patients With Prostate Cancer Status TERMINATED Phase PHASE1
NCT04478279 A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04446117 Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04335682 Androgen Receptor Directed Therapy on Cognitive Function in Patients Treated With Darolutamide or Enzalutamide Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04332744 Enzalutamide Plus Talazoparib for the Treatment of Hormone Sensitive Prostate Cancer (ZZ-First) Status COMPLETED Phase PHASE2
NCT04330716 Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers Status COMPLETED Phase NA
NCT04262154 Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04220983 PRAGMA (Prostate Radio Ablation Guided by Magnetic Resonance Imaging Acquisition) in Metastatic Prostate Cancer Status COMPLETED Phase NA
NCT04193657 Toward a Comprehensive Supportive Care Intervention for Older or Frail Men With mCRPC Status COMPLETED Phase N/A
NCT04179864 A Study of Tazemetostat With Enzalutamide or Abiraterone/Prednisone in Participants With Advanced Prostate Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT04140526 Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04086966 PSMA-PET/MRI for Radiation Treatment Planning in Patients With Locally Metastatic Prostate Cancer: A Pilot Study Status COMPLETED Phase PHASE1
NCT04085991 Two TraCer PositROn EmiSSion Tomography ComBination for Efficacy EstimatiOn of Prostate Specific Membrane Antigen Radioligand Therapy in Patients With Metastatic Prostate Cancer Status TERMINATED Phase PHASE2
NCT04070209 Management of Oligoprogressive Castration Resistant Prostate Cancer (PCS X) Status RECRUITING Phase PHASE2
NCT04067713 Plasma Analysis for Response Assessment and to DIrect the manaGement of Metastatic Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase N/A